Scholar Rock Holding (SRRK) Operating Leases (2019 - 2026)
Scholar Rock Holding (SRRK) recorded quarterly Operating Leases of $3.0 million in Q1 2026, down 18.38% quarter-over-quarter from $3.7 million in Q4 2025, and down 62.25% on a YoY basis from $7.9 million in Q1 2025.
Scholar Rock Holding (SRRK) Operating Leases (2019 - 2026) Analysis & Trends
Scholar Rock Holding's Operating Leases history runs 8 years deep, the most recent figure standing at $3.0 million for Q1 2026.
- In Q1 2026, Operating Leases fell 62.25% year-over-year to $3.0 million; the TTM figure through Mar 2026 stood at $3.0 million (down 62.25% YoY), while the FY2025 annual figure was $3.7 million, down 60.29% from the prior year.
- Operating Leases was $3.0 million for Q1 2026 at Scholar Rock Holding, down from $3.7 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $17.7 million in Q1 2022 to a low of $2.4 million in Q1 2024.
- Historically, Operating Leases has averaged $8.7 million across 5 years, with a median of $8.2 million in 2023.
- The sharpest annual moves came in 2024 and 2025: Operating Leases sank 75.95% in 2024, then jumped 227.74% in 2025.
- A 5-year view of Operating Leases shows it stood at $11.8 million in 2022, then sank by 62.78% to $4.4 million in 2023, then jumped by 109.61% to $9.2 million in 2024, then sank by 60.29% to $3.7 million in 2025, then slipped by 18.38% to $3.0 million in 2026.
- The last three Operating Leases figures came in at $3.0 million (Q1 2026), $3.7 million (Q4 2025), and $5.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Scholar Rock Holding | 5.57 Bn | 5.09 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.98 Mn |
| Dec 31, 2025 | 3.66 Mn |
| Sep 30, 2025 | 5.14 Mn |
| Jun 30, 2025 | 6.56 Mn |
| Mar 31, 2025 | 7.91 Mn |
| Dec 31, 2024 | 9.21 Mn |
| Sep 30, 2024 | 10.47 Mn |
| Jun 30, 2024 | 11.77 Mn |
| Mar 31, 2024 | 2.41 Mn |
| Dec 31, 2023 | 4.39 Mn |
| Sep 30, 2023 | 6.34 Mn |
| Jun 30, 2023 | 8.23 Mn |
| Mar 31, 2023 | 10.03 Mn |
| Dec 31, 2022 | 11.80 Mn |
| Sep 30, 2022 | 13.54 Mn |
| Jun 30, 2022 | 15.65 Mn |
| Mar 31, 2022 | 17.67 Mn |
| Dec 31, 2021 | 19.65 Mn |
| Sep 30, 2021 | 21.60 Mn |
| Jun 30, 2021 | 23.52 Mn |